Overview

Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)

Status:
Terminated
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if Metformin is safe and useful in the treatment of NAFLD.
Phase:
Phase 4
Details
Lead Sponsor:
Manal Abdelmalek
Treatments:
Metformin